Report Overview
The Indian Brain Cancer market size stood at around USD XX Billion in 2019 and is projected to reach USD XX Billion by 2028, exhibiting a CAGR of XX% during the forecast period.
Brain cancers include primary brain tumours, which start in the brain and rarely spread to other parts of the body, and secondary tumours (or metastases), which are caused by cancers that began in another part of the body. The incidence of central nervous system (CNS) tumors in India ranges from 5 - 10 % 100,000 population with an increasing trend. Metastatic brain tumors occur when cancer located in another organ of the body spreads to the brain.40% of all cancers spread to brain. Brain and central nervous system tumors are also the second most common cancers in children, accounts for about 26% of childhood cancers. In 2018, brain tumours was ranked as the 10th most common kind of tumour among Indians. The International Association of Cancer Registries (IARC) reported that there are over 28,000 cases of brain tumours reported in India each year and more than 24,000 people reportedly die due to brain tumours annually. The growth is attributed to the growing burden of brain tumor, raising awareness and increasing R&D on cancer therapeutics. A brain tumour occurs when abnormal cells form within the brain. There are two major types of tumors, malignant or cancerous tumors and benign tumours.
Market Drivers
The market size drivers for the growth of brain cancer diagnostics are expected to propel by technological developments, improvements in diagnostics machines, the increasing prevalence of neurological disorders, Neurological disorders are identified as one of the most prevalent disorders, due to longer life expectancy, increasing exposure to infections and sedentary lifestyle, rise in the number of cigarette smokers responsible for brain cancer has contributed to the market size, rising prevalence of neurological disorders among children and adults is set to be one of the vital factors driving the brain cancer drugs market growth. Brain disorders comprise an amalgamation of neurodegenerative, developmental, and psychiatric diseases.
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.